Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$39.5 - $64.42 $7,900 - $12,884
-200 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$43.74 - $62.76 $8,748 - $12,552
200 New
200 $13,000
Q4 2020

Feb 12, 2021

SELL
$42.19 - $51.5 $8,438 - $10,300
-200 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$35.33 - $51.04 $7,066 - $10,208
200 New
200 $10,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.